NO was shown to promote cancer progression through an activation of oncogenic signaling pathways including the extracellular signal-regulated kinases (ERK) 1/2, phosphoinositide 3-kinases (PI3K)/AKT, and cMyc [32]. The gene discussed is MYC; the disease is cancer.